Sign up to The Irish Times Archive (1859 - 2008)My Account »
Sat 08 Aug 2008Tysabri users not properly monitored, says expert
PATIENTS WITH multiple sclerosis (MS) who are taking the drug Tysabri are not being properly monitored for serious side effects because of health service budgetary cutbacks, a leading neurologist has warned.
Following the announcement yesterday of two new cases of progressive multifocal leukoencephalopathy (PML), a known Tysabri side-effect, by the manufacturer, Biogen, Dr Orla Hardiman, consultant neurologist at Beaumont Hospital, Dublin said she was not surprised at the finding. "This shows the surveillance [for side-effects] has worked."
Choose a Subscription type - required
